We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Membrane Protein Enables Tuberculosis Bacteria to Avoid Phagosome Destruction

By LabMedica International staff writers
Posted on 13 Aug 2008
Microbiologists have identified a survival mechanism that allows the tuberculosis bacteria to survive in the phagosomes of macrophages under conditions that destroy most types of bacteria.

Acidification of the phagosome is considered a major mechanism used by macrophages against bacteria, including Mycobacterium tuberculosis (Mtb). More...
However, Mtb is able to flourish under acidic conditions when grown in the laboratory and is able to survive the acidic environment of the phagosome.

To discover the mechanism used by Mtb to survive under acidic conditions, investigators at Weill Cornell Medical College (New York, NY, USA) used transposon mutagenesis to identify genes responsible for Mtb's acid resistance. They reported in the July 20, 2008, online edition of the journal Nature Medicine that a mutant strain lacking the gene Rv3671c, which codes for a previously uncharacterized membrane-associated protein, was sensitive to acid and failed to maintain intrabacterial pH in acid in vitro and in activated macrophages. Growth of the mutant strain was also severely weakened in mice.

The authors suggest that discovery of drugs targeted against Rv3671c and capable of disrupting Mtb's acid resistance and intrabacterial pH maintenance systems is an urgent priority.

"M. tuberculosis does not depend on Rv3671c under standard growth conditions in the test tube, so it has been overlooked as a candidate drug target,” explained contributing author Dr. Carl F. Nathan, professor of microbiology and immunology at Weill Cornell Medical College. "What is clear is that by targeting an element involved directly in the infective process, we may develop a line of drugs that work in collaboration with, rather than in difference to, the host environment, including host immune responses. Hopefully, this kind of approach can help solve the ongoing problem of bacterial drug resistance.”

Related LInks:
Weill Cornell Medical College



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.